Leelyn Smith’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-35
| Closed | -$9.69K | – | 143 |
|
|
2022
Q4 | $9.69K | Sell |
35
-78
| -69% | -$21.6K | ﹤0.01% | 323 |
|
|
2022
Q3 | $30K | Sell |
113
-1,238
| -92% | -$329K | 0.01% | 189 |
|
|
2022
Q2 | $276K | Sell |
1,351
-8,620
| -86% | -$1.76M | 0.07% | 109 |
|
|
2022
Q1 | $2.1M | Buy |
9,971
+1,943
| +24% | +$409K | 0.55% | 56 |
|
|
2021
Q4 | $1.93M | Buy |
8,028
+78
| +1% | +$18.7K | 0.52% | 57 |
|
|
2021
Q3 | $2.25M | Buy |
7,950
+825
| +12% | +$233K | 0.65% | 43 |
|
|
2021
Q2 | $2.47M | Sell |
7,125
-436
| -6% | -$151K | 0.73% | 41 |
|
|
2021
Q1 | $2.12M | Buy |
7,561
+345
| +5% | +$96.5K | 0.63% | 45 |
|
|
2020
Q4 | $1.77M | Buy |
7,216
+681
| +10% | +$167K | 0.57% | 53 |
|
|
2020
Q3 | $1.85M | Buy |
6,535
+735
| +13% | +$209K | 0.65% | 40 |
|
|
2020
Q2 | $1.12M | Buy |
5,800
+627
| +12% | +$121K | 0.46% | 62 |
|
|
2020
Q1 | $1.64M | Buy |
5,173
+1,168
| +29% | +$370K | 0.87% | 27 |
|
|
2019
Q4 | $1.19K | Buy |
+4,005
| New | +$1.19K | 0.57% | 53 |
|